Nuclear Medicine Market to See USD 6,683.99 Mn Worth by 2027: Growth Factors & Trends

Nuclear Medicine, Global Nuclear Medicine, Nuclear Medicine Market, Nuclear Medicine Market Size, Nuclear Medicine Industry, Nuclear Medicine Market share, Nuclear Medicine Sales, Nuclear Medicine Industry Analysis, Nuclear Medicine Industry Demand, Nuclear Medicine Industry Trends, Nuclear Medicine Market Analysis, Nuclear Medicine Market Data, Nuclear Medicine Market Demand, Nuclear Medicine Market Forecasts

Big Market Research recently introduced new title on “2019-2027 Nuclear Medicine Market Report” that provides an in-depth overview of industry and competitive landscape, covering multiple market segments and elaborates market outlook and status to 2027.

The global nuclear medicine/radiopharmaceuticals market is expected to reach US$ 6,683.99 Mn in 2027 from US$ 3,982.11 Mn in 2018. The market is estimated to grow with a CAGR of 6.2% from 2019-2027.

Request for a sample copy of this report @

The market for nuclear medicine/radiopharmaceuticals is expected to grow, owing to factors such as rising prevalence of chronic diseases, alpha radioimmunotherapy-based targeted oncology treatment and advancement in imaging technologies using radiopharmaceuticals play vital role in the growth of the radiopharmaceuticals market. However, the restraints such as short shelf-life of radiopharmaceuticals and availability of substitutes of radiopharmaceuticals are likely to impact the growth of the market in the forecast period.

A radiopharmaceutical is a drug, which can be used either for diagnostic or therapeutic purposes. Radiopharmaceuticals are radioisotopes that are bound to biological molecules that target specific tissues, organs, or cells within the human body. Radioisotopes emitting gamma rays are useful for diagnostic imaging where the radiation escapes the body. These rays are detected by a specific device, which is usually single-photon emission computed tomography (SPECT)/ positron emission tomography (PET) cameras.

The shelf-life or expiry date of a radiopharmaceutical preparation depends mainly on the half-life of the radioisotope, the radiochemical stability and the content of longer-lived radionuclide impurities in the preparation under consideration. Most of the radiopharmaceutical preparations contain radioisotopes with very short half-lives and such preparations have very short shelf-lives. These preparations require an expiry date and time to be indicated. For example, technetium based preparations and positron emission tomography (PET) preparations are generally intended to be used within less than 12 hours, or sometimes within few minutes of preparation. Hence, the short shelf-life of radiopharmaceuticals are expected to hinder the growth of the market in the future years.

Global nuclear medicine/radiopharmaceuticals were segmented by application and end user. The application segment was segmented as diagnostic applications and therapeutic applications. Based on the end user, the market was segmented as hospitals and diagnostic centers. During 2018, the hospitals segment led the nuclear medicine/radiopharmaceuticals market by the end user.

Some of the major primary and secondary sources included in the report for, Society of Nuclear Medicine, Food and Drug Administration, American Cancer Society, World Health Organization, American Hospital Association (AHA), National Cancer Institute (NCI), Canadian Association of Nuclear Medicine, and others.

Request for a Discount Sample @


By Application

  • Diagnostic Applications
    • SPECT (Single-Photon Emission Computed Tomography) Applications
    • PET (Positron Emission Tomography) Applications
  • Therapeutic Applications
    • Thyroid
    • Bone Metastasis
    • Lymphoma
    • Endocrine Tumors
    • Other Therapeutic Applications 

By End User

  • Hospitals
  • Diagnostic Centers

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
    • Argentina 

Company Profiles

  • Cardinal Health
  • IBA Worldwide
  • Curium
  • Bayer AG
  • Positron Corporation
  • NTP Radioisotopes SOC Ltd.
  • Bracco
  • Lantheus Medical Imaging Inc.
  • Advanced Accelerator Applications

Access Full Summery @

Table of content:

  1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Market – By Applications

1.3.2 Global Nuclear Medicine/Radiopharmaceuticals Market – By End User

1.3.3 Global Nuclear Medicine/Radiopharmaceuticals Market – By Geography

  1. Global Nuclear Medicine/Radiopharmaceuticals Market – Key Takeaways
  2. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

  1. Global Nuclear Medicine/Radiopharmaceuticals Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

About Us:

Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.

We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact Us:

Mr. Abhishek Paliwal

5933 Ne Win Sivers Drive, #205, Portland,

Or 97220 United States

Call Answer Direct:+1-971-202-1575

Call Answer Toll Free:+1-800-910-6452